A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Desiree Rodriguez lost 35 pounds on a drug like Ozempic — but the tradeoff was losing “clumps” of her hair. She spoke to The Post about how she managed to minimize the hair loss.

A phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving with low-dose semaglutide. HealthDay News — Low-dose semaglutide seems to reduce craving and certain ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...